Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2023-05-21 Report Publication Anno…
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Updates
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the publication of results for the quarter and year ended 31.3.2023. It mentions the results were published on 6th May 2023 in newspapers. The document is about the announcement of financial results publication rather than the full financial report itself. The length is 15,000 characters, but the content is primarily a notification letter with some attached or referenced financial results. There is no detailed financial data or analysis within the text provided, only a notice of publication. Therefore, this fits the category of Report Publication Announcement (RPA) rather than an Annual Report (10-K) or Interim Report (IR).
2023-05-21 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-11 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document contains detailed tabular disclosures of related party transactions, including loans, remuneration, interest paid, rent paid, and consultancy charges involving key managerial personnel and their relatives. The content focuses on financial dealings between the company and related parties, with approval remarks by the audit committee. There is no indication that this is a full annual report, audit report, or earnings release. Instead, it is a specific disclosure related to related party transactions, which is typically part of regulatory compliance filings. The document length is 5727 characters, which is substantial but the content is narrowly focused on related party transactions rather than comprehensive financial statements or management discussion. This type of disclosure is best classified under Regulatory Filings (RNS) as it does not fit other more specific categories and is a compliance-related disclosure.
2023-05-05 English
Outcome of Board Meeting
Regulatory Filings
2023-05-05 English
Financial Result Updates
Regulatory Filings
2023-05-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-05-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.